Axsome Therapeutics (AXSM) Change in Inventory (2022 - 2026)

Axsome Therapeutics' Change in Inventory history runs 5 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 1149.0% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $13.5 million (up 2353.5% YoY), while the FY2025 annual figure was $10.7 million, up 1532.8% from the prior year.
• Change in Inventory came in at $3.1 million for Q1 2026 at Axsome Therapeutics, down from $3.6 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $5.0 million in Q3 2025 to a low of -$1.7 million in Q3 2023.
• A 5-year average of $1.5 million and a median of $1.3 million in 2023 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory slumped 681.82% in 2023 and soared 1149.0% in 2026, its largest moves.
• Axsome Therapeutics' Change in Inventory stood at $1.3 million in 2022, then jumped by 269.74% to $4.9 million in 2023, then sank by 76.9% to $1.1 million in 2024, then soared by 222.41% to $3.6 million in 2025, then retreated by 14.56% to $3.1 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $3.1 million, $3.6 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison